
Koppers (KOP) Stock Forecast & Price Target
Koppers (KOP) Analyst Ratings
Bulls say
Koppers Holdings Inc. reported a significant increase in adjusted EBITDA, rising by 78.1% to $5.04 million, which reflects strong operating leverage and operational efficiency. The company's gross profit surged by 43.7% to $12.2 million, supported by a higher gross margin and an increase in revenue from its Pharmaceutical segment. Furthermore, the average quarterly revenue per program rose by 52% to $75,434, indicating robust growth in program performance and enhancing the overall revenue trajectory for the company.
Bears say
Koppers Holdings Inc. has experienced a significant decline in financial performance, with adjusted EBITDA decreasing by 34.8% to $26.1 million primarily due to lower sales volumes and increased raw material costs. Consolidated sales fell by 12.4% to $485.3 million, with the railroad and utility products and services segment reporting a 6.2% year-over-year decrease, reflecting reduced demand from key customers. Additionally, the carbon materials and chemicals segment faced a 16.4% decline in net sales, exacerbating concerns regarding the overall market share and operational profitability of the company.
This aggregate rating is based on analysts' research of Koppers and is not a guaranteed prediction by Public.com or investment advice.
Koppers (KOP) Analyst Forecast & Price Prediction
Start investing in Koppers (KOP)
Order type
Buy in
Order amount
Est. shares
0 shares